Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Debt / NOTE 1.000% 9/1
-
Market price (% of par)
-
129.9%
-
Total 13F principal
-
$981,078,530
-
Principal change
-
-$24,950,000
-
Total reported market value
-
$1,277,359,156
-
Number of holders
-
70
-
Value change
-
-$13,039,270
-
Number of buys
-
23
-
Number of sells
-
37
Institutional Holders of ALNYLAM PHARMACEUTICALS INC - NOTE 1.000% 9/1 as of Q2 2025
As of 30 Jun 2025 ALNYLAM PHARMACEUTICALS INC - NOTE 1.000% 9/1 had 70 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $981,078,530 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included Voya Investment Management LLC, DEERFIELD MANAGEMENT COMPANY, L.P., STEELHEAD PARTNERS LLC, Davidson Kempner Capital Management LP, LAZARD ASSET MANAGEMENT LLC, TENOR CAPITAL MANAGEMENT Co., L.P., Invesco Ltd., Calamos Advisors LLC, Aequim Alternative Investments LP, and Opti Capital Management, LP.
This table shows 70 bond principal holders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par) |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.